phosphatidylcholines has been researched along with afimoxifene in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (afimoxifene) | Trials (afimoxifene) | Recent Studies (post-2010) (afimoxifene) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 1,255 | 10 | 325 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | afimoxifene (IC50) |
|---|---|---|---|
| Phospholipase D2 | Homo sapiens (human) | 6.5 | |
| Estrogen receptor | Homo sapiens (human) | 0.0105 | |
| Estrogen-related receptor gamma | Homo sapiens (human) | 0.0084 | |
| Phospholipase D1 | Homo sapiens (human) | 6.5 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.0102 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, LM; Custódio, JB; Madeira, VM | 1 |
| Aranda, FJ; Ortiz, A; Ortiz, J; Teruel, JA | 1 |
2 other study(ies) available for phosphatidylcholines and afimoxifene
| Article | Year |
|---|---|
The active metabolite hydroxytamoxifen of the anticancer drug tamoxifen induces structural changes in membranes.
Topics: Animals; Cholesterol; Dimyristoylphosphatidylcholine; Fluorescence Polarization; Lipid Bilayers; Liposomes; Luminescent Measurements; Membrane Lipids; Muscles; Phosphatidylcholines; Rabbits; Sarcoplasmic Reticulum; Structure-Activity Relationship; Tamoxifen; Thermodynamics | 1993 |
Dissimilar action of tamoxifen and 4-hydroxytamoxifen on phosphatidylcholine model membranes.
Topics: Phosphatidylcholines; Tamoxifen | 2021 |